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Abstract
Background: Clot strength by Thrombelastography (TEG) is associated with mortality during trauma and has been
linked to severity of tissue hypoperfusion. However, the optimal method for monitoring this important relationship
remains undefined. We hypothesize that oxygen transport measurements will be associated with clot strength
during traumatic shock, and test this hypothesis using a swine model of controlled traumatic shock.
Methods: N = 33 swine were subjected to femur fracture and hemorrhagic shock by controlled arterial bleeding
to a predetermined level of oxygen debt measured by continuous indirect calorimetry. Hemodynamics, oxygen
consumption, systemic central venous oxygenation (ScvO2), base excess, lactate, and clot maximal amplitude by
TEG (TEG-MA) as clot strength were measured at baseline and again when oxygen debt = 80 ml/kg during shock.
Oxygen transport and metabolic markers of tissue perfusion were then evaluated for significant associations with
TEG-MA. Forward stepwise selection was then used to create regression models identifying the strongest
associations between oxygen transport and TEG-MA independent of other known determinants of clot strength.
Results: Multiple markers of tissue perfusion, oxygen transport, and TEG-MA were all significantly altered during
shock compared to baseline measurements (p < 0.05). However, only ScvO2 demonstrated a strong bivariate
association with TEG-MA measured during shock (R = 0.7, p < 0.001). ScvO2 measured during shock was also
selected by forward stepwise selection as an important covariate in linear regression models of TEG-MA after
adjusting for the covariates fibrinogen, pH, platelet count, and hematocrit (Whole model R
2 = 0.99, p ≤ 0.032).
Conclusions: Among multiple measurements of oxygen transport, only ScvO2 was found to retain a significant
association with TEG-MA during shock after adjusting for multiple covariates. ScvO2 should be further studied for
its utility as a clinical marker of both tissue hypoxia and clot formation during traumatic shock.
Background
Disordered hemostasis is present in up to 1/4 of severely
injured trauma patients upon initial emergency depart-
ment evaluation [1]. When present, it is associated with a
four-fold increased mortality regardless of injury severity
[1]. Clinical data and animal models have thus far, yielded
strong evidence for a distinct biochemical aetiology for
this early phemomenon that includes deregulated
fibrinolysis and anticoagulation via the protein-C pathway
that is linked to decreased vascular perfusion with tissue
hypoxia [2-4].
Base deficit/excess has been used as the primary mar-
ker of tissue hypoxia used to predict early coagulopathy,
mortality, and transfusion requirements in trauma
patients [1,5-7]. In addition, blood lactate concentration
is currently used to define the severity of hemorrhagic
shock in animal models of trauma [4]. However, these
metabolic markers of shock severity, while being readily
clinical available, are not direct reflections of tissue
hypoxia and can be affected by other factors during
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ethanol intoxication, thus limiting their utility [8-10].
Viscoelastic tests of clot formation such as Thrombe-
lastography (TEG™) or Rotational Thrombelastometry
(ROTEM™), have identified reduced clot strength, pro-
longed clot initiation times, and increased fibrinolysis in
trauma patients [11-15]. Of these viscoelastic para-
meters, estimates of clot strength (maximal amplitude
by TEG, and maximal clot firmness by ROTEM) are
becoming increasingly favoured due to their good repro-
ducibility and high sensitivity to the development coagu-
lopathy and outcomes when compared to plasma-based
assays [16,17]. Viscoelastic clot strength is an aggregate
measurement that is dependent on multiple blood com-
ponents including platelet activity and concentration,
fibrinogen concentration, pH, hematocrit, and tempera-
ture [18-20]. It is this presence of multiple confounding
influences on both markers of shock severity and viscoe-
lastic clot strength that has made it difficult to precisely
define how tissue perfusion is associated with changes
in clot strength during trauma.
We have previously reported that clot strength by
TEG is reduced in isolation prior to fluid resuscitation
during traumatic shock in an oxygen debt-driven animal
model [21]. This model affords a unique opportunity to
examine the important relationships between changes in
oxygen metabolism and clot strength during controlled
traumatic shock in more detail. Better understanding of
these relationships will inform further focused study on
potential monitoring modalities and mechanisms of
abnormal clot formation in the setting of traumatic
shock.
In this study, we examine associations between oxygen
transport/metabolism and clot strength by TEG in a
swine model of controlled traumatic shock. We hypothe-
size that direct oxygen transport measurements will be
associated with clot strength when measured during
shock.
Methods
Swine Traumatic Shock Protocol
We used a Virginia Commonwealth University Institu-
tional Animal Use Committee-approved swine model of
anesthetized traumatic shock that was consistent with
published international guidelines on the ethical treat-
ment of animals. This model has been extensively
described previously [21]. In brief, immature male swine
weighing 40-50 kg were sedated with intramuscular
ketamine/xylazine (20 and 2 mg/kg respectively) and
surgical-plane anesthesia was induced with intravenous
sodium pentathol (10-20 mg/kg). General anesthesia was
then maintained using either intravenous alfaxalone
(1 mg/kg bolus, 0.15 mg/kg/hr infusion) or alpha chlora-
lose bolus (40-50 mg/kg bolus, 10 mg/kg/hr infusion).
Of note, intravenous anesthesia was changed from alfax-
alone to alpha-chloralose midway through the study due
to difficulty obtaining a reliable supply of alfaxalone
anaesthetic. Following induction of anesthesia, subjects
were ventilated with room air (FiO2 = 21%) and respira-
tory rate was titrated to normalize PCO2 to 35-45
mmHg and was held constant for the remainder of the
protocol. Subjects were also instrumented for continu-
ous measurement of oxygen transport and hemody-
namics and intermittent measurement of blood
metabolism and coagulation during this period. After
the brief baseline stabilization period, oxygen consump-
tion (VO2) and mean arterial pressure (MAP) were
recorded and a sample of whole blood was collected
from the central venous circulation for blood gas, cell
counts, and coagulation studies.
To add a component of tissue injury, soft tissue of
both hind quarters was then traumatized and the right
midshaft femur was fractured using a captive-bolt pistol
causing an estimated Abbreviated Injury Scale (AIS)
equal to 3 for the extremities [22]. Midline laparotomy
was also performed using electrocautery and was
assigned an estimated AIS = 2 yielding a total Injury
Severity Score (ISS) equal to 13 [22].
Simultaneous with injury, the left femoral artery
catheter was opened and blood was allowed to flow
freely into a sealed graduated volumetric canister until
MAP reached a predetermined goal of 30-35 mmHg.
Hemorrhage was then halted and subjects maintained at
goal MAP until oxygen debt (OD) accumulated to
80 ml/kg calculated by continuous indirect calorimetry
at the airway. Goal MAP was maintained during the
shock period by additional small blood draws or small
aliquots (≤50 ml) of normal saline. Hemodynamic and
oxygen transport measurements were recorded again
and a second sample of whole blood for blood gas mea-
surements, cell counts, and coagulation were obtained
from the systemic central venous circulation at goal OD.
No resuscitation was attempted during this time period
and room air ventilation at the baseline rate was held
constant. Upon completion of the protocol, subjects
were euthanized by injection of potassium chloride
(2 ml/kg) under anesthesia. Normal porcine body tem-
perature (38° +/- 1 C) was maintained by a warming
blanket and monitored continuously by rectal probe.
Measurements
VO2, oxygen deficit, and OD were measured continu-
ously breath by breath using indirect calorimetry at the
airway at a frequency of 200 measurements per minute
and were recorded using integrated software (BIOPAC
Systems Inc., Goleta, CA). OD represents the total oxy-
gen deficit accumulated over time during shock. OD
starts at zero at baseline and increases in proportion to
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during hemorrhagic shock. Previous work has demon-
strated that OD is a sensitive marker of shock severity
and a reliable predictor of mortality in similar swine
models [23,24].
Blood gas analysis was made using the Stat Profile
Critical Care Xpress bedside analyzer (Nova Biomedical
Corp., Waltham, MA) to measure pH, base excess (BE),
systemic central venous oxygen saturation (ScvO2),a n d
lactate concentration. The VetScan HM2 Hematology
System, bedside analyzer (Abaxid, Union City, CA) was
used to measure leukocyte count (WBC), hemoglobin
concentration (Hgb), and platelet count (Plt). Blood for
coagulation studies was collected into citrated vacutai-
ners from a central venous catheter (Edwards Life
Sciences, Irvine, CA) placed through the internal jugular
vein to the right atrium as verified by pressure waveform.
The START-4 coagulation analyzer (Diagnostica Stago,
Asnières, France) was used to measure prothrombin time
(PT) activated partial thromboplastin time (aPTT), and
fibrinogen in platelet-poor plasma after centrifugation.
TEG (TEG 5000, Haemoscope Corporation, Niles, IL) by
recalcification (10 mmol/l final calcium concentration)
was performed in whole blood according to manufacturer
specifications at 37°C after 30 minutes and up to 3 hours
after blood draw in all cases, which is a longer period
than recommended by the manufacturer, but has demon-
strated stability using citrated and recalcified samples
[25]. TEG parameters measured included: clot onset time
(R), clot formation (or kinetics) time (K), clotting angle
(Angle), maximal clot strength (MA), and shear elastic
modulus (G). All devices were calibrated as directed by
the manufacturers.
Variable Selection
Our overall goal was to examine the associations
between changes in markerso fo x y g e nt r a n s p o r ta n d
changes in viscoelastic clot strength. In order to do so,
linear regression models were developed using TEG-MA
as the primary outcome variable due to its sensitivity in
identifying early functional coagulation changes com-
pared to plasma-phase assays [17]. MA is an aggregate
measure of clot strength and is influenced by blood pH,
temperature, platelet count and activity, and fibrinogen
concentration. No exact description of the relative con-
tribution of each underlying factor to the overall devel-
opment of MA exists, although, it is generally accepted
that MA is primarily determined by platelet function
and fibrinogen concentration [19,20]. The TEG “func-
tional fibrinogen™” assay can isolate the fibrin contribu-
tion to MA using platelet inhibition. However, this assay
was not included in our study because a similar throm-
belastometry assay (FIBTEM™) was found not to be
applicable to porcine blood [26]. We also included all
known and measurable determinants of MA that were
not standardized during the hemorrhage protocol.
Therefore, the variables Plt, fibrinogen, pH, and Hct
were considered as possible covariates when building
the regression models due to their known influence on
MA. These variables were included primarily to deter-
mine their role as covariates or confounders when eval-
uating the relationship between oxygen transport and
clot strength, and will be referred to as making up the
‘covariates’ group for simplicity.
Direct measurements of VO2,S c v O 2,B Ea n dl a c t a t e
were considered as the primary oxygen transport vari-
ables in the analysis. VO2 represents total body oxygen
consumption and is calculated by the difference in abso-
lute volume of inhaled and exhaled oxygen with each
breath. BE represents the number of hypothetical base
units required to return a sample of blood to neutral phy-
siologic pH. Negative BE values during shock can repre-
sent tissue hypoperfusion with metabolic acidosis. ScvO2
represents the hemoglobin oxygen saturation in the cen-
tral venous circulation and is determined by both the
supply of oxygen to the tissues and the degree to which
oxygen is extracted from the blood by the tissues. Lactate
is a by-product of anaerobic metabolism and increases as
mitochondrial oxygen supplies become limited and meta-
bolism shifts to predominantly anaerobic glycolysis.
Bivariate Analysis
The first step in selecting the appropriate variables for
inclusion in the linear regression models was to deter-
mine the existence of strong bivariate relationships
within each group of variables. This step identified any
significant colinearity or interaction that might affect
the final regression models. Oxygen transport and cov-
ariates were evaluated for 1
st order bivariate correlations
among variables within each group. In addition, MA at
b a s e l i n ea n dM Aa tO D=8 0m l / k gw e r ec o r r e l a t e di n
order to determine the influence of the baseline values
on the values recorded during shock. Our primary inter-
est is in the effect of the change in oxygen transport and
its relationship to the change in clot strength. Therefore
t h ed i f f e r e n c e( Delta) between each variable at baseline
and during shock was also calculated and subjected to
bivariate correlation within each group.
The second step in selecting variables for inclusion
into linear regression models was to identify the predic-
tor variables having the strongest bivariate relationship
w i t hM A .T h e r e f o r e ,e a c hp r e d i c t o r ’s first- and second-
order terms were related to both MA at OD = 80 ml/kg
and Delta MA.
Linear Regression
Predictor variables demonstrating moderate bivariate
correlation (R > 0.4) with the value of MA measured
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regression analysis. In the event of significant colinearity
between oxygen transport variables, we planned to select
the single representative oxygen transport variable with
the strongest correlation with MA to include in the final
regression analysis. This variable was then made avail-
able for selection as an independent variable during
final model selection along with the described covariates
and their interaction terms. Several linear regression
models were then selected using forward stepwise vari-
able selection with the absolute value of MA measured
during shock and Delta MA as the two dependent out-
comes. All statistical analysis was performed using JMP
8.0.1® statistical software (SAS Institute Inc. Cary, NC).
Results
A total of 33 swine weighing (Mean/std) 45.7(5.4) kg
completed the traumatic hemorrhage protocol and
achieved OD = 81.3(3) ml/kg after a period of 81.7(31.2)
minutes in shock. Blood loss was 1089.2(319.3) ml, or
24 ml/kg, and animals received 85.7(184.6) ml of saline
to maintain goal MAP during shock. Core temp was
37.9(0.6) deg C at the end of the shock period. Of these
subjects, 52% (17/33) were anesthetized using alfaxalone
anesthesia before changing to alpha chloralose. Paired
T-test revealed no significant difference in MA recorded
at baseline, during shock, or the change in MA between
the two anesthetic regimens (p > 0.2). Consequently, the
type of anesthesia was not included as a covariate in the
final analysis.
Table 1 demonstrates the mean value of each oxygen
transport, cell count, and coagulation variable recorded
during the protocol at baseline and during shock. On
average, all oxygen transport variables changed signifi-
cantly from baseline to shock. In addition, average lac-
tate increased to >6 mmol/L during shock indicating
that a severe shock state was achieved. This level of lac-
tate met previously used criteria for the development of
coagulopathy in other animal models [4]. These changes
were accompanied by a mild shift towards acidosis dur-
ing shock that was significantly different from baseline
values.
Hemoglobin, hematocrit, and platelet count were each
decreased by 9-10% during shock compared to baseline
measurements. (Table 1) This likely suggests a degree of
auto resuscitation or mild dilution taking place during
the hemorrhagic shock period which may have been
amplified by continuous maintenance of hypotensive
blood pressure by selective blood draws and normal sal-
ine titration [27].
Overall, coagulation parameters reflected no change in
clot formation kinetics with a reduced, but not abnor-
mal, MA in the setting of low fibrinogen. PT was
slightly, but significantly, prolonged during shock when
compared to baseline yielding a PT baseline/shock ratio
of 1.05. In addition, aPTT was shortened but not signifi-
cantly so, and fibrinogen fell significantly to approxi-
mately 54% of baseline values during shock. MA
demonstrated a statistically significant 5% reduction dur-
ing shock when compared to baseline values (68.7-65.2
mm, respectively) but did not become abnormal by stan-
dard definitions.
Bivariate Analysis
Of the measured oxygen transport variables, significant
colinearity was found only between the Delta BE and the
Delta lactate during shock (R = -0.66, p < 0.001) and the
absolute values of BE and lactate measured during shock
(R = -0.7, p < 0.001). Of the covariates, significant coli-
nearity was found between the Delta fibrinogen and the
Delta pH (R = -0.59, p = 0.03). Among all other possible
combinations, we found that fibrinogen and lactate mea-
sured during shock correlated negatively (R = -0.59, p =
0.03). Blood pH and VO2 measured during shock also
correlated negatively (R = -0.80, p < 0.001). No other sig-
nificant bivariate relationships between oxygen transport
variables and covariates were found.
MA measured during shock was found to have a high-
degree of positive correlation with baseline MA (R =
0.69, p = 0.002). Therefore, baseline MA was used as a
covariate when identifying significant relationships
between oxygen transport variables and the point mea-
surement of MA during shock. This adjustment is
necessary to avoid undue influence of variation in base-
line MA between subjects. The same correction was not
needed when examining the relationship between the
predictor variables and the Delta MA for each subject.
Of note, there was no bivariate association between
volume of saline administered during shock and MA
measured at OD = 80 ml/kg or the Delta MA (p > 0.2).
We then determined 1
st and 2
nd order associations of
each predictor variable with MA measured during shock
(adjusted for baseline MA) and the Delta MA. Of the
oxygen transport predictor variables, only ScvO2 was
found to have a significantly positive 2
nd order associa-
tion with MA measured during shock after adjustment
for baseline MA (overall model R
2= 0.7, p < 0.001). In
addition, ScvO2 measured during shock had a signifi-
cant positive 2
nd order correlation with the Delta MA
(R
2 = 0.69, p = 0.01).
Multiple Linear Regressions
The ScvO2 2
nd order term was then used to represent
oxygen transport in all models due to its strong bivariate
relationship with MA. No colinearity was found between
the value of ScvO2 measured during shock or the
change in ScvO2 from baseline and other oxygen trans-
port variables. Two multivariate models (Table 2) were
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0.25 probability to enter as follows:
1. The first regression model used the value of MA
measured during shock as the dependent outcome
variable. The covariates fibrinogen, pH, Hct, and Plt
measured during shock and the 2
nd order ScvO2
term adjusted for baseline MA (y = b0 + b1(ScvO2)
+ b2(MA at baseline) + b3(ScvO2
2)w e r em a d ea v a i l -
able for selection as independent variables. Interac-
tion terms between ScvO2 and each covariate were
also made available for possible inclusion in the final
Table 1 Summary of oxygen transport, physiologic, and coagulation measurements
Baseline Hemorrhagic Shock
Mean Mean Mean Diff Std Err Diff 95% CI Diff. p value
Hemodynamics/Perfusion
MAP (mmHg) 110.1 29.7 -80.4 2.9 -86.7 -74.2 < 0.001
VO2 (ml/kg/min) 4.8 3.9 -1.1 0.1 -1.2 -0.9 < 0.001
ScvO2 (%) 65.1 18.4 -47.7 2.2 -52.1 -43.3 < 0.001
BE 1.8 -3.5 -5.6 0.7 -7.1 -4.2 < 0.001
Lactate (mmol/L) 1.5 7.1 +5.8 0.4 4.9 6.6 < 0.001
pH 7.42 7.35 -0.07 0.01 -0.09 -0.05 < 0.001
Coagulation
PT (sec) 13.1 13.8 +0.7 0.3 0 1.4 0.048
aPTT (sec) 25.3 23 -2.3 1.7 -6.2 1.6 0.207
Fibrinogen (mg/dl) 154.5 82.8 -87.8 15.4 -121.5 -54.2 < 0.001
Thrombelastography
R (min) 5.4 5.1 0.0 0.4 -0.8 0.8 1.0
K (min) 1.5 1.5 0.0 0.1 -0.2 0.2 1.0
Angle (°) 70.5 70.2 -0.8 1.9 -3.3 4.9 0.67
MA (mm) 68.7 65.2 -3.5 0.9 -5.3 -1.7 < 0.001
G (dynes/cm sqr.) 11275.2 9592.3 -1660.6 399.8 -2508.2 813.1 < 0.001
Cell Counts
WBC (10^9/L) 13.9 14.5 -0.2 0.8 -1.9 1.5 0.83
Hgb (g/dl) 9.9 8.9 -1.0 0.2 -1.5 -0.5 < 0.001
Hct (%) 29.8 27 -2.7 0.6 -3.9 -1.5 < 0.001
Plt (10^9/L) 299.2 270.2 -24.7 10.6 -46.4 3 0.27
Data presented as mean, mean difference and standard error of the difference with 95% confidence intervals. Baseline measurements made prior to onseto f
hemorrhagic shock. Hemorrhagic shock measurements made after hemorrhage and a period of shock when Oxygen Debt = 80 ml/kg. All metabolic, coagulation,
and cell counts measured from central venous blood samples. VO2= Total body oxygen consumption; ScvO2%= percent systemic central venous oxyhemoglobin
saturation; BE = base excess of the extracellular fluid; PT = Prothrombin Time, aPTT = Activated Partial Thromboplastin Time; R = clot onset time, K = clot kinetics
time, Angle = clotting angle, MA = clot maximal amplitude, G = clot shear modulus, WBC = white blood cell count; Hgb = hemoglobin concentration; Hct =
percent hematocrit; Plt = Platelet Count
Table 2 Selected linear regression models
Independent Variable F Ratio p value Outcome Variable Whole Model R
2 Whole Model p value
ScvO2 57.7 0.083 Clot Strength (MA) at OD = 80 ml/kg 0.99 0.032
MA (baseline) 513 0.028
Fibrinogen 44.7 0.095
Hematocrit 5.6 0.113
ScvO2
2 1.5 0.44
ScvO2 508.5 0.028 Delta Clot Strength (MA) 0.99 0.029
Fibrinogen 830.6 0.022
Platelet count 52 0.088
ScvO2
2 338.2 0.035
(ScvO2*Platelet count) 141.9 0.053
Summary of 2 linear regression models selected by forward stepwise variable selection per Materials and Methods. Each overall model was highly predictive of
the MA measured during shock (OD = 80 ml/kg) or the change (Delta) in MA from baseline to shock. Fibrinogen and ScvO2 played important roles within each
selected model.
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and Hct measured during shock were added to the
2
nd order ScvO2 terms, making the final selected
model highly predictive of MA during shock (R
2 =
0.99, p = 0.02). However, within the selected model
there was no retained independent effect of the 2
nd
order ScvO2 term on MA after adjusting for the
added covariates.
Equation MA at OD ml kg
ScvO at OD ml kg
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2. The second regression model utilized the Delta
MA as the outcome variable. Again, the 2
nd order
ScvO2 terms measured during shock were used as a
starting point for forward variable selection. The
same independent variables measured during shock
with interaction terms were then added as possible
covariates. The final selected model consisted of the
ScvO2 second order term in addition to fibrinogen,
Plt, and the interaction term (Plt*ScvO2). The overall
model was highly predictive of the change in MA
from baseline (Whole model R
2 = 0.99, p = 0.029).
In this case, the 2
nd order ScvO2 term and fibrino-
gen each retained a significant effect on the Delta
MA.
Equation Delta MA
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Discussion
Swine Model
The animal model satisfactorily produced a severe state
of supply-dependent hemorrhagic shock by oxygen
transport and metabolic markers which became signifi-
cantly abnormal when OD = 80 ml/kg. However, the
severe shock state combined with injury produced only
an isolated reduction in MA without overt coagulopathy
by standard definitions.
One reason for the lack of overt coagulopathy during
shock may be our limited level of tissue injury. We
calculated the total ISS = 13, which is less than that
identified by Brohi et al, as being compatible with early
coagulopathy [1]. However, the goal of the study was to
isolate and examine the associations between tissue oxy-
gen perfusion parameters and clot strength rather than
to produce a significant overall coagulopathy. Increasing
extremity injury would not have increased the ISS in
our model per se. Thoracic injury would have likely
confounded our oxygen debt measurements by impair-
ing pulmonary oxygen exchange. Adding abdominal
solid organ injury would have detracted from our ability
to standardize shock severity due to uncontrolled
hemorrhage. Inducing traumatic brain injury would
have induced specific changes in clotting function, mak-
ing interpretation of our results difficult. For these rea-
sons, we limited ISS in order to better examine the
specific associations between oxygen transport variables
and TEG-MA.
Hypothermia was also prevented and plasma dilution
was limited to that occurring from transcapillary refill
and small aliquots of isotonic crystalloid during the
hypotensive period. The 9-10% reduction noted in Hct
and cell counts likely did not play a significant role in
the measured significant decrease in MA from baseline.
Small volume dilution of blood (less than 10% changes
in Hct) with isotonic crystalloid has been shown in vitro
to instead produce procoagulant properties to the blood
and increase MA in healthy humans [28]. Overall, the
animal model achieved the stated goal by providing an
experimental platform in which significant changes in
both oxygen transport and clot strength were achieved
in the setting of traumatic shock, but should not be
interpreted as producing an overt coagulopathy by cur-
rent definitions.
Porcine models of coagulopathy in the setting of
trauma are popular and favored because they use a large
mammalian species that shares gross cardiovascular
physiology with humans. Swine are amenable to precise
monitoring while providing adequate sample volumes
for viscoelastic testing. A review of experimental trau-
matic coagulopathy models found that of 33 models
deemed appropriate for review, 17 were porcine [29].
However, significant differences exist in the type of coa-
gulation changes produced in swine in response to
hemorrhage and these differences are important to con-
sider when interpreting our results.
Standard tests of blood coagulation function typically
demonstrate pro-coagulant activity in swine compared
to humans, and immunologic methods are not generally
comparable as illustrated in a comparison of 22 com-
mercial assays in healthy pigs and humans by Munster
et al [30]. The authors found that PT was approximately
equal between species while aPTT was shorter in pigs
suggesting enhanced intrinsic coagulation cascade
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4-fold higher in pigs, which may have special relevance
in the setting of trauma since coagulopathic trauma
patients have demonstrated increased plasma tissue fac-
tor activity [31]. Using ROTEM, comparisons of porcine
and human clot formation also suggest a hypercoagul-
able state in pigs relative to humans. Pigs tend to
demonstrate shorter clot formation times, faster clot
buildup, and increased maximal clot firmness with simi-
lar clot lysis profiles to humans [26,32]. TEG parameters
correlate with ROTEM in porcine blood, with TEG
demonstrating higher values for clotting angle and clot
strength (MA vs. MCF) [33]. Therefore, the native
hypercoagulable state of porcine blood relative to
humans may require that a greater degree of shock or
increased injury severity be incurred in order to accu-
rately reproduce the early coagulation changes seen in
humans. This species difference may have contributed
to our lack of overt coagulopathy during shock.
To date, no porcine model has accurately reproduced
the initial hemostatic changes observed in human trau-
matic coagulopathy. Sapsford et al, observed no change
in PT after 40% hemorrhage compared to baseline mea-
surements using an aortic tear model [34]. Martini et al,
observed no difference in PT, R, K, Angle, and a signifi-
cant, but limited, reduction in MA (approx 67 to 63 mm)
measured 4 hours after 35% hemorrhage combined with
crystalloid resuscitation of 3 times shed blood volume
[17,35]. Via et al, reported in their sham resuscitation
group no change in PT, PTT, or fibrinogen, and a reduc-
tion in TEG-MA from 74-71 mm at one hour of shock
after a 40% blood volume hemorrhage [36]. Using
ROTEM, Haas et al, reported that clotting time and clot
formation time were essentially unchanged and maximal
clot firmness was reduced, but not necessarily abnormal,
after a 60% blood volume hemorrhage [37]. Cho et al,
reported a multi-institute porcine model that, similar to
ours, added femur fracture by captive-bolt pistol [38].
When compared to our model, they achieved a similar
injury profile, hemorrhage volume, and a similar level of
lactate accumulation during shock. Their coagulation
parameters measured at “End of Shock” after injury and
hemorrhage, but prior to fluid resuscitation, are most
likely comparable to our OD = 80 ml/kg measurements.
At this particular time point, they found an INR baseline/
shock ratio of only 1.1 and TEG parameters demonstrat-
ing a trend towards hypercoagulability (R, K, and Angle)
with an isolated decrease in MA that was not outside the
baseline reference range [38]. Overall, the available vis-
coelastic porcine data demonstrates a tendency for iso-
lated and limited decrease in clot strength as the initial
response to hemorrhage. This result agrees with our own
and is somewhat dissimilar to human observational stu-
dies which typically demonstrate a mixed impairment of
prolonged clot onset times and decreased clot strength.
This initial response may be species-specific. Alterna-
tively, current porcine models may lack the appropriate
criteria (combined shock and injury severity) to induce
very early coagulopathy similar to that seen in humans.
Our model is also limited in this respect since we
achieved only and ISS = 13. Therefore, our results, while
consistent with other porcine models, may not be directly
comparable to traumatic coagulopathy observed in
human studies.
Fibrinogen Consumption
Fibrinogen was rapidly consumed during shock, consis-
tent with previously published results using similar
swine models. This likely reflects an increased consump-
tive process associated with the injury and shock state
since acidosis was minimal [39,40]. Systemic venous pH
and lactate both correlated with fibrinogen during
shock. Direct acidification of the blood can reduce cir-
culating fibrinogen levels by increasing breakdown with-
out increasing production [40]. However, the underlying
mechanism of this effect of pH on fibrinogen metabo-
lism remains unknown. In addition, the lack of a direct
association of oxygen consumption with fibrinogen and
the mild overall acidosis indicates that the reduction in
fibrinogen we observed should not be attributed entirely
to the effects of tissue hypoperfusion or acidosis. Alter-
natively, the rapid consumption of fibrinogen may be
attributable to the chosen pattern of injury since femur
fracture and femur fracture manipulation have been
associated with rapid consumption of fibrinogen in both
animal models and human studies [41,42].
Oxygen Transport and Clot Strength
Forward variable stepwise selection revealed that ScvO2,
fibrinogen, Hct, and platelet count were important pre-
dictors of clot strength in this animal model. There was
also evidence for an interaction between ScvO2 and pla-
telet count in determining Delta MA during shock sug-
gesting a specific role for platelets. Each selected linear
regression model was highly predictive of both the value
of MA during shock and Delta MA from baseline. The
lack of a direct association between VO2 and clot
strength and the importance of ScvO2 as the only signifi-
cant oxygen transport associated with MA was interest-
ing and surprising. This finding was even more
surprising when considering that BE and lactate, the cur-
rent metabolic markers used clinically to define tissue
hypoperfusion, shared no association with clot strength
in our animal model. Lactate did correlate with fibrino-
gen concentration during shock, but was not directly
associated with MA. Therefore, it is possible that fibrino-
gen may have confounded an underlying association
between lactate and clot strength. Alternatively, another
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tionship, but was not sufficiently pronounced in our
model.
The reason why ScvO2 was more strongly associated
with clot strength when compared to other direct markers
of oxygen transport or tissue hypoperfusion remains
unclear. One explanation is that lactate produced in hypo-
perfused tissues may not have reached the central circula-
tion by “wash out” prior to reperfusion, thus lactate may
be less accurate than ScvO2 in terms of hypoperfusion
prior to fluid resuscitation. Among hemodynamic and
oxygen transport measurements, ScvO2 has been found
by Scalea et al, to be the best predictor of acute blood loss
in experimental trauma models [43]. The authors suggest
that this sensitivity is a result of the ability of ScvO2 to
reflect early increasing oxygen extraction at the blood/tis-
sue interface in response to hemorrhage before gross
hemodynamic measurements become abnormal.
In our study, the same sensitivity of ScvO2 to early
changes in oxygen extraction may potentially explain its
strong association with clot strength via compensatory
endothelial activation in response to hypoxia. The
observed fall in ScvO2 and VO2 with a concurrent
increase in lactate confirms that oxygen delivery to the
tissues was reduced below critical levels, despite maximal
oxygen extraction. In addition, the disproportionately
large fall in ScvO2 from baseline levels (reduced 72%)
when compared to VO2 (reduced 19%) suggests that
blood oxygen extraction was actively enhanced at the
blood/endothelial interface during shock. Therefore, we
speculate that ScvO2 and clot strength may be associated
via activation of the endothelium as part of the local
endothelial response to hypoxic conditions [44]. While
we did not directly measure biomarkers of endothelial
activation, further evidence for a link between ScvO2,
protein C, and endothelial activation was recently
reported by Trecziak et al. in critically ill septic patients.
The authors used ScvO2 to measure hypoxia and its
effect on coagulation measurements and found that a
subgroup of patients with both abnormally low ScvO2
plus hypotension demonstrated changes in protein C,
thrombomodulin, and increased endothelial activation by
E-selectin expression [45]. Therefore, our findings taken
in this context may indirectly support the mechanism
put forth by Brohi et al., who described a critical role for
endothelial activation of protein C in the pathophysiology
of trauma-induced coagulopathy [2]. Future research on
this topic should seek to include biomarkers of endothe-
lial activation when examining associations between tis-
sue hypoxia/hypoperfusion and clot formation.
Limitations
We acknowledge that there are distinct limitations to
this study. As discussed, the relevance of the swine
model to human subjects is concerning due to the
native differences between porcine and human coagula-
tion function. In addition, we calculated the coefficient
of variation (CV) for swine MA measured at baseline in
t h es t u d yo fC h oe ta l . ,a n df o u n di tt or a n g ef r o m
12-20% across centers [38]. Our 5% change in MA from
baseline to shock is well within this range, further limit-
ing our results. In addition, tissue injury was limited and
the model itself achieved only a mild reduction in clot
strength without overt coagulopathy. We also did not
strictly standardize the timing of TEG test performance,
possibly adding variability to our results. However, when
taken in the context of other similar swine models of
hemorrhage, the changes in clot strength in our model
were quite similar to those described by other investiga-
tors when measured during shock and prior to fluid
resuscitation.
We intended to isolate the association between oxygen
metabolism and clot strength so to examine the inher-
ent relationships in detail. As a result, we can only spec-
ulate on the associations found between independent
and dependent variables and cannot make any causative
or mechanistic conclusions from the data. Nevertheless,
the associations found suggest important areas for
further focused study concerning the early detection and
monitoring of hemostasis during trauma.
Conclusions
In summary, ScvO2 was associated with reduced clot
strength by TEG during traumatic shock in this swine
model of controlled hemorrhage. Fibrinogen, hematocrit,
and platelet counts were found to be important covari-
ates in this relationship. These findings suggest that,
perhaps due to its association with tissue oxygen extrac-
tion, ScvO2 deserves further study as a potentially useful
clinical marker of both tissue perfusion and clot forma-
tion during trauma.
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